Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 39, 2009 - Issue 9
347
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling

, , , , &
Pages 637-648 | Received 02 Mar 2009, Accepted 07 Apr 2009, Published online: 29 May 2009

References

  • Agoram B, Woltosz WS, Bolger MB. (2001). Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev 50(Suppl. 1):S41–67.
  • Allan G, Davis J, Dickins M, Gardner I, Jenkins T, Jones H, Webster R, Westgate H. (2008). Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man. Xenobiotica 38:620–40.
  • Berezhkovskiy LM. (2004). Volume of distribution at steady-state for a linear pharmacokinetic system with peripheral elimination. J Pharm Sci 93:1628–40.
  • Chauret N, Gauthier A, Nicoll-Griffith DA. (1998). Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab Dispos 26:1–4.
  • Dressman JB, Vertzoni M, Goumas K, Reppas C. (2007). Estimating drug solubility in the gastrointestinal tract. Adv Drug Deliv Rev 59:591–602.
  • Edginton AN, Theil FP, Schmitt W, Willmann S. (2008). Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opin Drug Metab Toxicol 4:1143–52.
  • Huang C, Zheng M, Yang Z, Rodrigues AD, Marathe P. (2008). Projection of exposure and efficacious dose prior to first-in-human studies: how successful have we been? Pharm Res 25:713–26.
  • Inoue S, Howgate EM, Rowland-Yeo K, Shimada T, Yamazaki H, Tucker GT, Rostami-Hodjegan A. (2006). Prediction of in vivo drug clearance from in vitro data. II: Potential inter-ethnic differences. Xenobiotica 36:499–513.
  • Jamei M, Marciniak S, Feng K, Barnett A, Tucker G, Rostami-Hodjegan A. (2009). The Simcyp((R)) population-based ADME simulator. Expert Opin Drug Metab Toxicol 5:211–223.
  • Jones HM, Parrott N, Jorga K, Lave T. (2006). A novel strategy for physiologically based predictions of human pharmacokinetics. Clin Pharmacokinet 45:511–42.
  • Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. (2004). Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 1:85–96.
  • Parrott N, Lave T. (2008) Applications of physiologically based absorption models in drug discovery and development. Mol Pharm 5:760–75.
  • Poulin P, Schoenlein K, Theil FP. (2001). Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs. J Pharm Sci 90:436–47.
  • Poulin P, Theil FP. (2000). A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci 89:16–35.
  • Poulin P, Theil FP. (2002a). Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. J Pharm Sci 91: 1358–70.
  • Poulin P, Theil FP. (2002b). Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci 91:129–56.
  • Proctor NJ, Tucker GT, Rostami-Hodjegan A. (2004). Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors. Xenobiotica 34:151–78.
  • Rodgers T, Rowland M. (2006). Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 95:1238–57.
  • Rodgers T, Rowland M. (2007). Mechanistic approaches to volume of distribution predictions: understanding the processes. Pharm Res 24:918–33.
  • Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, Fleisher D, Lee KD, Amidon GL. (2002). Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res 19:1400–16.
  • Winiwarter S, Bonham NM, Ax F, Hallberg A, Lennernas H, Karlen A. (1998). Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J Med Chem 41:4939–49.
  • Yang J, Jamei M, Yeo KR, Tucker GT, Rostami-Hodjegan A. (2007) Prediction of intestinal first-pass drug metabolism. Curr Drug Metab 8:676–84.
  • Yu LX, Amidon GL. (1999) A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm 186:119–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.